α‑Glucosidase and α‑amylase Inhibitory assay of Fractions and Crude Extract of Zingiber officinale (Ginger) and Evaluation of Its Antioxidant (ABTS and DPPH) Activity

Murtadha M Hussein A Kadhim (1) , Zainab Mohammed Jassim (2) , Ali Hamad Abd Kelkawi (3)
(1) Department of Applied Biotechnology, College of Biotechnology, Al-Qasim Green University, Iraq. , Iraq
(2) Department of Applied Biotechnology, College of Biotechnology, Al-Qasim Green University, Iraq. , Iraq
(3) Department of Medical Physics, College of Applied Medical Sciences, University of Kerbala, Iraq. , Iraq

Abstract

Objectives: The objective of this work was to provide an investigation into the antioxidant, α-glucosidase, and α-amylase inhibitory properties of the crude extract and fractions of the Zingiber officinale plant.


Background: It is possible to find members of the Zingiberaceae family in both the southern and eastern regions of Asia. Plants such as Zingiber officinale (often known as ginger) and Curcuma longa (also known as turmeric) are examples of members of this family that are frequently utilized in herbal medicine. As an additional benefit, these plants are widely used as a component of polyherbal medications for the treatment of diabetes mellitus.


Methods: For the goal of assessing the antioxidant activity, a free radical scavenging assay were carried out. Furthermore, a substrate-based enzyme inhibition experiment was conducted in order to ascertain whether or not Zingiber officinale possessed inhibitory actions directed towards α-glucosidase and α-amylase.

Full text article

Generated from XML file

References

Crichton, M., Marshall, S., Marx, W., McCarthy, A.L. and Isenring, E. (2019). Efficacy of ginger (Zingiber officinale) in ameliorating chemotherapy-induced nausea and vomiting and chemotherapy-related outcomes: A systematic review update and meta- analysis. Journal of The Academy of Nutrition and Dietetics, 119(12), 2055–2068.

Danwilai, K., Konmun, J., Sripanidkulchai, B.O. and Subongkot, S. (2017). Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: A pilot study. Cancer Management Research, 9, 11–18.

El-Gayar, M.H., Aboromia, M.M.M., Ibrahim, N.A. and Abdel-Hafiz, M.H. (2019). Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus. Obesity Medicine, 14, 100094.

El-Ghorab, A.H., Nauman, M., Anjum, F.M., Hussain, S. and Nadeem, M.A. (2010). Comparative study on chemical composition and antioxidant activity of ginger (Zingiber officinale) and cumin (Cuminum cyminum). Journal of Agricultural Food Chemistry, 58(14), 8231–8237.

Ahn, E. K. & Oh, J. S. 2012. Inhibitory effect of galanolactone isolated from Zingiber officinale Roscoe extract on adipogenesis in 3T3-L1 Cells. Journal of Korean Society for Applied Biological Chemistry, Vol.55, pp.63–68.

Chang, W. T., Thissen, U., Ehlert, K. A, Koek, M. M., Jellema, R. H., Hankemeier, T., van der Greef, J. & Wang, M. 2006. Effects of growth conditions and processing on Rehmannia glutinosa using fingerprint strategy. Planta Medica, Vol.72, pp.458–467.

Chareonkla, A., Pohmakotr, M., Reutrakul, V., Yoosook, C., Kasisit, J., Napaswad, C. & Tuchinda, P. 2011. A new diarylheptanoid from the rhizomes of Zingiber mekongense. Fitoterapia, Vol.82, pp.534–538.

D. Shrestha, T. Pokhrel, K. Dhakal, A. Pandey, P. Sharma, and S. Sapkota, “α-Glucosidase and α-amylase inhibition study and in silico analysis of Mimosa pudica L. of Nepalese origin,” Current Bioactive Compounds, vol. 18, pp. 2–8, 2022.

A. B. Olokoba, O. A. Obateru, and L. B. Olokoba, “Type 2 diabetes mellitus: a review of current trends,” Oman Medical Journal, vol. 27, no. 4, pp. 269–273, 2012.

C. Lankatillake, T. Huynh, and D. A. Dias, “Understanding glycaemic control and current approaches for screening an- tidiabetic natural products from evidence-based medicinal plants,” Plant Methods, vol. 15, no. 1, p. 105, 2019.

A. I. Martinez-Gonzalez, ´AG. D´ıaz-S´anchez, L. A. Rosa, C. L. Vargas-Requena, I. Bustos-Jaimes, and E. Alvarez-Parrilla, “Polyphenolic compounds and digestive enzymes: in vitro non-covalent interactions,” Molecules, vol. 22, no. 4, p. 669, 2017.

D. Shrestha, P. Sharma, A. Adhikari, A. K. Mandal, and A. Verma, “A review on Nepalese medicinal plants used traditionally as alpha-amylase and alpha-glucosidase inhibitors against diabetes mellitus,” Current Traditional Medicine, vol. 7, no. 5, p. 1, 2021.

T. Pokhrel, D. Shrestha, K. Dhakal, P. M. Yadav, and A. Adhikari, “Comparative analysis of the antioxidant and antidiabetic potential of Nelumbo nucifera gaertn. And nymphaea lotus L. Var. pubes1,” Journal of Chemistry, vol. 2022, Article ID 4258124, 5 pages, 2022.

Y. M. Kim, M. H. Wang, and H. I. Rhee, “A novel α-glucosidase inhibitor from pine bark,” Carbohydrate Research, vol. 339, no. 3, pp. 715–717, 2004.

M. Toeller, “α-Glucosidase inhibitors in diabetes: efcacy in NIDDM subjects,” European Journal of Clinical Investigation, vol. 24, no. S3, pp. 31–35, 2010.

N. Saito, H. Sakai, S. Suzuki, H. Sekihara, and Y. Yajima, “Efect of an α-glucosidase inhibitor (voglibose), in combi- nation with sulphonylureas, on glycaemic control in type 2 diabetes patients,” Journal of International Medical Research, vol. 26, no. 5, pp. 219–232, 1998.

K. Dhakal, D. Shrestha, T. Pokhrel et al., “Antioxidant, an- tibacterial, antidiabetic potential, and in silico analysis of rhus chinensis from western Nepal,” Current Topics in Medicinal Chemistry, vol. 22, no. 26, pp. 2145–2151, 2022.

Z. X. Zhu, J. H. Wang, Y. C. Cai, K. K. Zhao, M. J. Moore, and H. F. Wang, “Complete plastome sequence of Erythropalum scandens (Erythropalaceae), an edible and medicinally important liana in China,” Mitochondrial DNA Part B, vol. 3, no. 1, pp. 139-140, 2018.

D. T. Vu and T. A. Nguyen, “Te neglected and underutilized species in the Northern mountainous provinces of Vietnam,” Genetic Resources and Crop Evolution, vol. 64, no. 6, pp. 1115–1124, 2017.

S. Sutha, A. Maruthupandian, V. R. Mohan, and T. Athiperumalsami, “Anti-infammatory activity of leaf of Erythropalum scandens bl., bijdr against carrageenan induced paw edema,” Int J PharmTech Res CODEN, vol. 3, no. 1, pp. 24–26, 2011.

S. Kupina, C. Fields, M. C. Roman, and S. L. Brunelle, “Determination of total phenolic content using the Folin-C assay: single-laboratory validation, frst action 2017.13,” Journal of AOAC International. 2018; 101 (5): 1466–1472.

C.-C. Chang, M.-H. Yang, H.-M. Wen, and J.-C. Chern, “Estimation of total favonoid content in propolis by two complementary colometric methods,” Journal of Food and Drug Analysis. 2020; 10(3).

L. L. Mensor, F. S. Menezes, G. G. Leitão. Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method,” Phytotherapy Research. 2001; 15(2): 127–130.

M. Telagari and K. Hullatti, “In-vitro α-amylase and α-glucosidase inhibitory activity of Adiantum caudatum Linn. and Celosia argentea Linn. extracts and fractions,” Indian Journal of Pharmacology. 2015; 47(4):425–429.

Authors

Murtadha M Hussein A Kadhim
Zainab Mohammed Jassim
Ali Hamad Abd Kelkawi
A Kadhim , M. M. H. ., Jassim , Z. M. ., & Kelkawi , A. H. A. (2023). α‑Glucosidase and α‑amylase Inhibitory assay of Fractions and Crude Extract of Zingiber officinale (Ginger) and Evaluation of Its Antioxidant (ABTS and DPPH) Activity. Journal of Current Medical Research and Opinion, 6(12), 1949–1961. Retrieved from https://cmro.in/index.php/jcmro/article/view/681

Article Details